Frontiers in Urology | Urologic Oncology

Original Research

Published on 12 Dec 2022

Body mass index and immune checkpoint inhibitor efficacy in metastatic cancer patients: A Brazilian retrospective study

in Urologic Oncology

Raphael Brandao Moreira
Mauricio Fernandes
Mariana Ribeiro Monteiro
Francine Maria Agostinho Luiz
Erika Simplicio Silva
Perla de Mello Andrade
Mayara Batista Pinto
Letycia Lima
Astrid Silva
Juliana Nunez

Frontiers in Urology

doi 10.3389/fruro.2022.1069045

1,285 views
3 citations

Original Research

Published on 23 Nov 2022

Prostate volume is an independent predictive factor in selecting low-risk prostate patients for active surveillance

in Urologic Oncology

Igor Yusim
Elad Mazor
Nimer Elsaraya
Roni Gat
Victor Novack
Nicola J. Mabjeesh

Frontiers in Urology

doi 10.3389/fruro.2022.990499

1,711 views

Editorial

Published on 04 Nov 2022

Editorial: Neoadjuvant systemic therapies in bladder, kidney, and prostate cancers

in Urologic Oncology

James Eastham
A. Ari Hakimi
Stephen Boorjian

Frontiers in Urology

doi 10.3389/fruro.2022.978751

654 views

Original Research

Published on 26 Oct 2022

Genitourinary cancers in the Arab world: A bibliometric study

in Urologic Oncology

Sarah Ibrahim
Theresa Farhat
Rim Baalbaki
Michael Aoun
Georgio Toumieh
Malak Kaddoura
Lubna Jaber
Ali T. Taher
Zahi Abdul-Sater

Frontiers in Urology

doi 10.3389/fruro.2022.955882

1,382 views

Review

Published on 10 Oct 2022

New therapies for neurovascular bundles regeneration after radical prostatectomy: A narrative review on clinical studies

in Urologic Oncology

Inés Rivero Belenchón
Juan Gómez Rivas
Rafael Antonio Medina López
Enrico Checcucci
Mark Taratkin
Stefano Puliatti
Karl-Friedrich Kowalewski
Giovanni Cacciamani
Carmen Belén Congregado Ruíz
Cristina Castro

Frontiers in Urology

doi 10.3389/fruro.2022.923064

4,203 views

Original Research

Published on 06 Oct 2022

Clinical actionability and utilization of next-generation sequencing for prostate cancer in a changing treatment landscape

in Urologic Oncology

Jacqueline Griffin
Che-Kai Tsao
Vaibhav Patel
Bobby C. Liaw
Sunny Guin
Himanshu Joshi
Michael Rossi
Feras Hantash
Xiang Zhou
Ash Tewari

Frontiers in Urology

doi 10.3389/fruro.2022.997396

2,497 views
3 citations

Original Research

Published on 20 Sep 2022

Cost-efficient analysis of a portable low field magnetic resonance imaging system for prostate cancer diagnosis

in Urologic Oncology

Christina Sze
Zaid Cheema
Aaron Laviana
Daniel Margolis
Daniel N. Costa
Poorvi Satya
Aleksander Nacev
Dinesh Kumar
Srirama S. Venkataraman
Bilal Chughtai

Frontiers in Urology

doi 10.3389/fruro.2022.966862

2,476 views
1 citation

Original Research

Published on 15 Sep 2022

Circulating PMN-MDSC level positively correlates with a poor prognosis in patients with metastatic hormone-sensitive prostate cancer

in Urologic Oncology

Yuki Kohada
Akito Kuromoto
Kazuya Takeda
Hiromichi Iwamura
Yuri Atobe
Jun Ito
Tomonori Kaifu
Yasuhiro Kaiho
Ichiro Nakashima
Nobuyuki Hinata

Frontiers in Urology

doi 10.3389/fruro.2022.967480

2,063 views
5 citations

Systematic Review

Published on 13 Sep 2022

The impact of non-modifiable sociodemographic factors on bladder cancer survival outcomes after radical cystectomy: A systematic review and cumulative analysis of population cohort studies

in Urologic Oncology

Wesley Yip
Andrew B. Chen
Michael F. Basin
Giovanni E. Cacciamani
Sumeet K. Bhanvadia

Frontiers in Urology

doi 10.3389/fruro.2022.934550

725 views

Review

Published on 02 Sep 2022

Neoadjuvant Systemic Therapies in Bladder Cancer

in Urologic Oncology

Carissa E. Chu
Gopa Iyer
Bernard H. Bochner

Frontiers in Urology

doi 10.3389/fruro.2022.890761

2,631 views

Original Research

Published on 24 Aug 2022

Targeting bladder urothelial carcinoma with pHLIP-ICG and inhibition of urothelial cancer cell proliferation by pHLIP-amanitin

in Urologic Oncology

Anna Moshnikova
Borivoj Golijanin
Ali Amin
Joshua Doyle
Ohad Kott
Boris Gershman
Michael DuPont
Yujing Li
Xiongbin Lu
Donald M. Engelman

Frontiers in Urology

doi 10.3389/fruro.2022.868919

2,983 views
6 citations

Review

Published on 29 Jul 2022

The Use of Androgen Deprivation Therapy in Combination With Radiation for Localized Prostate Cancer

in Urologic Oncology

Eric M. Anderson
Sean M. McBride

Frontiers in Urology

doi 10.3389/fruro.2022.890814

4,750 views
5 citations

Systematic Review

Published on 18 Jul 2022

PSMA as a Target for Advanced Prostate Cancer: A Systematic Review

in Urologic Oncology

Safiya-Hana Belbina
Mia Rose Schmolze
Sofia Gereta
Aaron A. Laviana

Frontiers in Urology

doi 10.3389/fruro.2022.912558

4,119 views
2 citations

Original Research

Published on 15 Jun 2022

Comparative Analysis of Primary Prostate Cancer Treatment and Subsequent Metastatic Disease

in Urologic Oncology

Mohammed Shahait
Nadine Hamieh
Ryan W. Dobbs
Tuan Nguyen
Hamzeh Alshannaq
Jessica Kim
Ayah El-Fahmawi
Daniel J. Lee
David I. Lee

Frontiers in Urology

doi 10.3389/fruro.2022.891798

2,156 views
1 citation

Review

Published on 12 May 2022

Predicting and Decreasing Bladder Tumor Recurrence Following Nephroureterectomy

in Urologic Oncology

Hiroko Miyagi
Elizabeth A. Di Valerio
Padraic O’Malley
Wayne G. Brisbane
Li-Ming Su
Paul L. Crispen

Frontiers in Urology

doi 10.3389/fruro.2022.903693

2,090 views
2 citations

Original Research

Published on 06 May 2022

Androgen Receptor Expression Is a Predictor of Poor Outcome in Urothelial Carcinoma

in Urologic Oncology

Bernadett Szabados
Sarah Duncan
Julia Choy
Francesca Jackson-Spence
Charlotte Toms
Giorgia Trevisan
Daniel M. Berney
Thomas Powles
Charlotte Ackerman

Frontiers in Urology

doi 10.3389/fruro.2022.863784

1,458 views
2 citations